STOCK TITAN

CDRE Form 144 details proposed sale of 1,343,941 common shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Cadre Holdings (CDRE) filed a Form 144 notice for the proposed sale of 1,343,941 common shares through broker Merrill Lynch on the NYSE, with an approximate sale date of 11/17/2025.

The shares listed have an aggregate market value of $56,566,477 based on the filing data. The filing reports that 40,663,844 shares of the issuer’s common stock are outstanding, providing context for the size of the potential sale.

The securities to be sold include shares acquired on 12/07/2021 via a liquidating distribution and shares acquired on 11/10/2025 upon the vesting and settlement of restricted stock units under the issuer’s 2021 Stock Incentive Plan.

Positive

  • None.

Negative

  • None.

Insights

Form 144 details a sizable potential insider sale relative to Cadre Holdings’ share count.

The notice states that 1,343,941 common shares of Cadre Holdings (CDRE) may be sold under Rule 144, with an aggregate market value of $56,566,477. These shares are to be sold through Merrill Lynch on the NYSE, with an approximate sale date of 11/17/2025. The filing also reports 40,663,844 shares outstanding, which helps frame the relative size of the proposed sale.

The securities include 86,903 shares acquired on 12/07/2021 via a liquidating distribution and 1,257,038 shares acquired on 11/10/2025 upon vesting and settlement of restricted stock units granted under the issuer’s 2021 Stock Incentive Plan. Because this is a notice of potential sales under Rule 144 rather than an issuance of new shares, the impact depends on whether, when, and how the holder executes sales within the disclosed parameters.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the CDRE Form 144 filing disclose?

The Form 144 for Cadre Holdings (CDRE) discloses a proposed sale of 1,343,941 common shares under Rule 144, with an aggregate market value of $56,566,477. The shares are planned to be sold through Merrill Lynch on the NYSE around 11/17/2025.

How large is the planned CDRE share sale compared to shares outstanding?

The filing reports that 1,343,941 common shares are proposed to be sold, while 40,663,844 common shares are outstanding. This gives investors a sense of the potential sale’s size relative to the total share count.

How were the Cadre Holdings shares in this Form 144 acquired?

The notice states that 86,903 shares were acquired on 12/07/2021 via a liquidating distribution based on Kanders SAF LLC’s pro rata membership interest in Maui Holdings LLC. A further 1,257,038 shares were acquired on 11/10/2025 upon the vesting and settlement of restricted stock unit awards under Cadre Holdings’ 2021 Stock Incentive Plan.

What trading venue and broker are listed for the CDRE Form 144 sale?

The filing lists Merrill Lynch, located at 225 Liberty St, 39th Floor, New York, NY 10281, as the broker, and names the NYSE as the securities exchange for the proposed sale of Cadre Holdings common shares.

What is the approximate sale date in the Cadre Holdings Form 144?

The Form 144 indicates an approximate sale date of 11/17/2025 for the proposed sale of 1,343,941 common shares of Cadre Holdings.

Are the CDRE shares in the Form 144 newly issued or existing shares?

The shares referenced are existing Cadre Holdings common shares, including those acquired via a 12/07/2021 liquidating distribution and those acquired on 11/10/2025 upon vesting and settlement of restricted stock units under the 2021 Stock Incentive Plan.

Cadre Hldgs Inc

NYSE:CDRE

CDRE Rankings

CDRE Latest News

CDRE Latest SEC Filings

CDRE Stock Data

1.72B
29.04M
29.12%
69.63%
4.85%
Aerospace & Defense
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Link
United States
JACKSONVILLE